Fosun Pharma Launches AI-Driven PharmAID Platform for Enhanced Drug Development
Fosun Pharma has introduced its self-developed PharmAID decision intelligence platform, integrating advanced AI technologies to boost drug R&D efficiency, announced in a press release. The platform is designed to enhance decision-making accuracy and accelerate the transformation of R&D achievements.
The PharmAID platform incorporates global leading large model technologies and connects with Deepseek R1, aiming to improve drug commercial value-assisted decision-making capabilities. It enhances drug R&D efficiency by integrating various predictive and analytical tools, such as point prediction, conformational prediction, and toxicology optimization.
Additionally, the platform offers AI translation and medical writing features, significantly improving information retrieval and writing efficiency. Fosun Pharma's initiative marks a significant step in the AI transformation of the pharmaceutical industry, aiming to lead innovation and transformation with its first self-developed AI decision intelligence platform.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like Life AI Weekly.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
Superagency in the Workplace: Empowering People to Unlock AI’s Full Potential
This report explores the transformative potential of artificial intelligence in the workplace, emphasizing the readiness of employees versus the slower adaptation of leadership. It highlights the significant productivity growth potential AI offers, akin to historical technological shifts, and discusses the barriers to achieving AI maturity within organizations. The report also examines the role of leadership in steering companies towards effective AI integration and the need for strategic investments to harness AI's full capabilities.
Read more